Palatin Technologies PTN
NASDAQ PTN
$12.02 -0.31 (-2.51%)
At close: Sep 10, 2026 · 4:00 PM EDT

Palatin Technologies (PTN) Other financing activities (2014 - 2026)

Palatin Technologies' (PTN) quarterly Other financing activities came in at $139510.0 in Q1 2026, up 65091.59% on a YoY basis from N/an in Q1 2025, and down 87.66% quarter-over-quarter from $1.1 million in Q4 2025.

Analysis

Palatin Technologies (PTN) Other financing activities (2014 - 2026) Analysis & Trends

Palatin Technologies (PTN) has reported Other financing activities for 8 consecutive years, with $139510.0 the latest figure, recorded in Q1 2026.

  • For the quarter ending Q1 2026, Other financing activities rose 65091.59% year-over-year to $139510.0; the trailing twelve-month figure through Mar 2026 stood at $1.6 million (up 746835.51% YoY), and the FY2025 full-year result was $3.4 million, down 43.79% from the prior year.
  • Other financing activities eased to $139510.0 in Q1 2026 per PTN's latest filing, from $1.1 million in the prior quarter.
  • Across five years, Other financing activities topped out at $1.1 million in Q4 2025 and bottomed at $78.0 in Q1 2023.
  • Historically, Other financing activities has averaged $319746.8 across 3 years, with a median of $139510.0 in 2026.
  • The widest YoY moves for Other financing activities: up 65091.59% in 2026, down 65091.59% in 2026.
  • Over 3 years, Other financing activities stood at $78.0 in 2023, then jumped by 1449556.41% to $1.1 million in 2025, then tumbled by 87.66% to $139510.0 in 2026.
  • According to Business Quant data, Other financing activities over the past three periods registered $139510.0, $1.1 million, and $328200.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn
10 Palatin Technologies 46.98 Mn 46.98 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 139,510.00
Dec 31, 2025 1.13 Mn
Sep 30, 2025 328,200.00
Mar 31, 2025 214.00
Mar 31, 2023 78.00
Jun 30, 2019 808,934.00
Jun 30, 2018 2.40 Mn
Sep 30, 2017 114,384.00
Jun 30, 2017 50,000.00
Mar 31, 2017 114,358.00
Jun 30, 2015 50,000.00
Jun 30, 2014 37,500.00